Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Cash from Operations (2024 - 2025)

Historic Cash from Operations for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$18.3 million.

  • Kestra Medical Technologies' Cash from Operations fell 158.95% to -$18.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$86.7 million, marking a year-over-year change of. This contributed to the annual value of -$77.6 million for FY2025, which is 743.82% down from last year.
  • Kestra Medical Technologies' Cash from Operations amounted to -$18.3 million in Q4 2025, which was down 158.95% from -$26.3 million recorded in Q3 2025.
  • Over the past 5 years, Kestra Medical Technologies' Cash from Operations peaked at -$14.9 million during Q2 2024, and registered a low of -$26.3 million during Q3 2025.